Total Payments
$1,253
2024 Payments
$14.45
Companies
16
Transactions
22
Medicare Patients
8,016
Medicare Billing
$2.8M
Payment Breakdown by Category
Food & Beverage$1,253 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,253 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $126.04 | 1 | $0 (2019) |
| Spark Therapeutics, Inc. | $121.84 | 1 | $0 (2019) |
| Aerie Pharmaceuticals, Inc. | $121.77 | 1 | $0 (2018) |
| Apellis Pharmaceuticals, Inc. | $118.91 | 1 | $0 (2023) |
| Mallinckrodt LLC | $117.64 | 2 | $0 (2018) |
| Horizon Therapeutics plc | $109.80 | 1 | $0 (2023) |
| EyePoint Pharmaceuticals US, Inc. | $106.24 | 1 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $100.04 | 1 | $0 (2019) |
| AbbVie, Inc. | $99.98 | 1 | $0 (2018) |
| Allergan, Inc. | $73.91 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.45 | 1 | Janssen Biotech, Inc. ($14.45) |
| 2023 | $275.76 | 4 | Apellis Pharmaceuticals, Inc. ($118.91) |
| 2022 | $119.20 | 2 | EyePoint Pharmaceuticals US, Inc. ($106.24) |
| 2020 | $17.91 | 1 | Allergan, Inc. ($17.91) |
| 2019 | $359.25 | 4 | UCB, Inc. ($126.04) |
| 2018 | $387.70 | 7 | Aerie Pharmaceuticals, Inc. ($121.77) |
| 2017 | $78.46 | 3 | Allergan Inc. ($56.00) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Immunology | ||||||
| 08/25/2023 | Organon LLC | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 07/19/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $118.91 | General |
| Category: Ophthalmology | ||||||
| 04/06/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $109.80 | General |
| Category: TEPEZZA | ||||||
| 02/10/2023 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $24.32 | General |
| 07/29/2022 | Exeltis, USA Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 05/05/2022 | EyePoint Pharmaceuticals US, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $106.24 | General |
| Category: Chronic Non-infectious Posterior Segment Uveitis | ||||||
| 11/06/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/18/2019 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $126.04 | General |
| 10/24/2019 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: OCULAR | ||||||
| 09/04/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $100.04 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/28/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Oncology | ||||||
| 12/12/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $106.90 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 12/07/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Oncology | ||||||
| 12/04/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $99.98 | General |
| 11/08/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $121.77 | General |
| Category: Ophthalmology | ||||||
| 10/09/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Oncology | ||||||
| 08/28/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 07/13/2018 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Oncology | ||||||
| 05/16/2017 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $56.00 | General |
| Category: RETINA | ||||||
| 03/21/2017 | AstraZeneca Pharmaceuticals LP | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Neuroscience | ||||||
| 03/07/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,121 | 4,371 | $1.6M | $581,310 |
| 2022 | 17 | 2,021 | 4,744 | $1.6M | $619,880 |
| 2021 | 14 | 1,888 | 4,987 | $1.9M | $751,264 |
| 2020 | 15 | 1,986 | 5,163 | $3.2M | $847,830 |
Total Patients
8,016
Total Services
19,265
Medicare Billing
$2.8M
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 51 | 536 | $995,352 | $370,877 | 37.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 74 | 493 | $104,023 | $42,116 | 40.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 359 | 484 | $124,872 | $38,445 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 321 | 380 | $85,880 | $37,333 | 43.5% |
| 92134 | Imaging of retina | Office | 2023 | 431 | 1,096 | $92,064 | $33,420 | 36.3% |
| J3590 | Unclassified biologics | Office | 2023 | 37 | 148 | $44,770 | $11,710 | 26.2% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 354 | 586 | $31,058 | $10,894 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 122 | $19,032 | $8,857 | 46.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 120 | 136 | $17,544 | $6,129 | 34.9% |
| 92250 | Photography of the retina | Office | 2023 | 186 | 213 | $19,809 | $5,596 | 28.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $12,180 | $4,091 | 33.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 31 | $9,393 | $4,046 | 43.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 29 | 65 | $21,450 | $3,740 | 17.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $7,568 | $2,560 | 33.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 12 | 15 | $2,715 | $926.77 | 34.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 14 | 16 | $1,744 | $567.27 | 32.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 40 | 522 | $967,497 | $375,133 | 38.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 470 | 1,000 | $257,937 | $90,322 | 35.0% |
| 67028 | Injection of drug into eye | Office | 2022 | 83 | 561 | $118,371 | $48,419 | 40.9% |
| 92134 | Imaging of retina | Office | 2022 | 455 | 1,167 | $98,009 | $35,845 | 36.6% |
| J3590 | Unclassified biologics | Office | 2022 | 44 | 268 | $58,960 | $23,187 | 39.3% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 371 | 592 | $31,378 | $10,926 | 34.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 162 | 178 | $22,962 | $8,437 | 36.7% |
| 92250 | Photography of the retina | Office | 2022 | 191 | 219 | $20,367 | $5,903 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 51 | $11,526 | $4,999 | 43.4% |
About Dr. Patrick Murphy, MD
Dr. Patrick Murphy, MD is a Ophthalmology healthcare provider based in Warren, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508849589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Murphy, MD has received a total of $1,253 in payments from pharmaceutical and medical device companies, with $14.45 received in 2024. These payments were reported across 22 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,253).
As a Medicare-enrolled provider, Murphy has provided services to 8,016 Medicare beneficiaries, totaling 19,265 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Warren, MI
- Active Since 11/23/2005
- Last Updated 03/31/2016
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1508849589
Products in Payments
- LUXTURNA (Biological) $121.84
- Rhopressa (Drug) $121.77
- Syfovre (Drug) $118.91
- ACTHAR (Biological) $117.64
- TEPEZZA (Drug) $109.80
- YUTIQ (Drug) $106.24
- VYZULTA (Drug) $100.04
- Rubraca (Drug) $70.38
- OZURDEX (Drug) $56.00
- HADLIMA (Drug) $22.73
- BOTOX (Biological) $17.91
- TREMFYA (Drug) $14.45
- PURIFIED CORTROPHIN GEL (Drug) $12.96
- MOVANTIK (Drug) $11.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Warren
Thomas Spoor, Md, MD
Ophthalmology — Payments: $17,448
Ophthalmology $17,448
Dr. Dominick Zangari, Md, MD
Ophthalmology — Payments: $7,477
Ophthalmology $7,477
Daniel Lin, Md, MD
Ophthalmology — Payments: $6,687
Ophthalmology $6,687
Dr. Alan Parent, M.d, M.D
Ophthalmology — Payments: $4,537
Ophthalmology $4,537
Dr. Matthew Gewirtz, M.d, M.D
Ophthalmology — Payments: $2,996
Ophthalmology $2,996
William Helwig, M.d, M.D
Ophthalmology — Payments: $1,559
Ophthalmology $1,559